Voltage-gated potassium channels — Drug Target

All drugs that target Voltage-gated potassium channels — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Potassium channel blocker

Marketed (1)

• SR-fampridine · University of Southern Denmark · Potassium channel blocker · Neurology
  SR-fampridine is a sustained-release formulation of fampridine that blocks potassium channels in nerve fibers, prolonging action potentials and enhancing nerve conduction.

Phase 3 pipeline (1)

• 3,4-diaminopyridine · Oregon Health and Science University · Potassium channel blocker · Neurology
  3,4-diaminopyridine blocks potassium channels to prolong action potential duration and increase acetylcholine release at the neuromuscular junction.

Phase 2 pipeline (1)

• Dalfampridine Pill · D'Youville College · Potassium channel blocker · Neurology
  Blocks potassium channels to enhance nerve conduction